$FOLD Headlines
Post# of 144503
Posted On: 09/24/2014 12:32:42 PM
$FOLD Headlines
Apple sets intraday record; PetSmart considers sale
1:56 p.m. Aug. 20, 2014
- Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade
8:05 a.m. Aug. 20, 2014
- Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial
8:04 a.m. Aug. 20, 2014
- Michael Calia
U.S. stocks rise as risk appetite returns
5:19 p.m. April 29, 2014
- Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats
3:49 p.m. April 29, 2014
- Sue Chang
U.S. stock futures climb; House prices flat in February
9:19 a.m. April 29, 2014
- Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results
7:25 a.m. April 29, 2014
- Sara Sjolin
Amicus rallies 52% premarket after positive trial results
7:08 a.m. April 29, 2014
- Sara Sjolin
Amicus stock down after it delays seeking Fabry OK
10:44 a.m. June 17, 2013
- MarketWatch.com
Friday’s biggest gaining and declining stocks
10:45 a.m. Jan. 4, 2013
- Greg Morcroft
Amicus Therapeutics up 11% in premarket
8:52 a.m. Jan. 4, 2013
- Steve Gelsi
Thursday’s movers: Apple ends in red on price cut
6:03 p.m. Dec. 20, 2012
- Sue Chang
Amicus down 45% in premarket
9:44 a.m. Dec. 20, 2012
- Steve Gelsi
Amicus falls 47% in premarket trades
8:52 a.m. Dec. 20, 2012
- Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours
7:31 p.m. Dec. 19, 2012
- Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal
6:22 p.m. Dec. 19, 2012
- MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours
5:45 p.m. Dec. 19, 2012
- Carla Mozee
U.S. Hot stocks to watch
7:28 a.m. July 18, 2012
- MarketWatch.com
U.S. may end patents on DNA: report
1:13 p.m. Oct. 30, 2010
- Christopher Hinton
Monday's biggest gaining and declining stocks
4:51 p.m. Oct. 5, 2009
- MarketWatch
3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus
1:25 p.m. Sept. 8, 2014
- benzinga.com
Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape
8:36 a.m. Sept. 3, 2014
- Zacks.com
InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical
10:13 a.m. Aug. 30, 2014
- Seeking Alpha
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
10:32 a.m. Aug. 27, 2014
- Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
9:49 a.m. Aug. 27, 2014
- Zacks.com
The Biotech Stock With The Best One-Week Performance
2:46 p.m. Aug. 25, 2014
- benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog
4:55 p.m. Aug. 21, 2014
- Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD)
9:45 a.m. Aug. 21, 2014
- TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape
9:39 a.m. Aug. 21, 2014
- Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape
9:03 a.m. Aug. 21, 2014
- Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)
3:43 p.m. Aug. 20, 2014
- Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today
10:29 a.m. Aug. 20, 2014
- TheStreet.com
Stocks Hitting 52-Week Highs
9:15 a.m. Aug. 20, 2014
- benzinga.com
Amicus Fabry disease drug candidate successful in Phase 3 trial
7:27 a.m. Aug. 20, 2014
- Seeking Alpha
Benzinga's Top #PreMarket Gainers
7:10 a.m. Aug. 20, 2014
- benzinga.com
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
6:01 a.m. Aug. 20, 2014
- TheStreet.com
Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript
9:37 p.m. Aug. 7, 2014
- Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC
5:07 p.m. Aug. 7, 2014
- Edgar Online - (EDG = 10Q, 10K)
Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape
8:44 a.m. Aug. 6, 2014
- Zacks.com
Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape
11:11 a.m. July 29, 2014
- Zacks.com
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics
8:40 a.m. Sept. 12, 2014
- PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo
8:40 a.m. Aug. 25, 2014
- PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
6:00 a.m. Aug. 20, 2014
- GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics
8:50 a.m. Aug. 13, 2014
- PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. Aug. 7, 2014
- GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
4:01 p.m. July 31, 2014
- GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis
8:50 a.m. July 30, 2014
- PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma
7:20 a.m. July 10, 2014
- PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc.
2:55 p.m. July 7, 2014
- PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array
6:30 a.m. July 3, 2014
- PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012
7:00 a.m. June 30, 2014
- GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum
8:20 a.m. June 4, 2014
- PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference
4:10 p.m. May 14, 2014
- GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. May 5, 2014
- GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive
Conference
10:30 a.m. May 5, 2014
- BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus
8:00 a.m. May 2, 2014
- PR Newswire - PRF
Amicus Therapeutics to Announce First Quarter 2014
10:01 a.m. May 1, 2014
- GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics
8:00 a.m. April 30, 2014
- PR Newswire - PRF
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011
6:01 a.m. April 29, 2014
- GlobeNewswire
Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference
4:39 p.m. March 27, 2014
- GlobeNewswire
Apple sets intraday record; PetSmart considers sale
1:56 p.m. Aug. 20, 2014
- Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade
8:05 a.m. Aug. 20, 2014
- Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial
8:04 a.m. Aug. 20, 2014
- Michael Calia
U.S. stocks rise as risk appetite returns
5:19 p.m. April 29, 2014
- Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats
3:49 p.m. April 29, 2014
- Sue Chang
U.S. stock futures climb; House prices flat in February
9:19 a.m. April 29, 2014
- Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results
7:25 a.m. April 29, 2014
- Sara Sjolin
Amicus rallies 52% premarket after positive trial results
7:08 a.m. April 29, 2014
- Sara Sjolin
Amicus stock down after it delays seeking Fabry OK
10:44 a.m. June 17, 2013
- MarketWatch.com
Friday’s biggest gaining and declining stocks
10:45 a.m. Jan. 4, 2013
- Greg Morcroft
Amicus Therapeutics up 11% in premarket
8:52 a.m. Jan. 4, 2013
- Steve Gelsi
Thursday’s movers: Apple ends in red on price cut
6:03 p.m. Dec. 20, 2012
- Sue Chang
Amicus down 45% in premarket
9:44 a.m. Dec. 20, 2012
- Steve Gelsi
Amicus falls 47% in premarket trades
8:52 a.m. Dec. 20, 2012
- Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours
7:31 p.m. Dec. 19, 2012
- Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal
6:22 p.m. Dec. 19, 2012
- MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours
5:45 p.m. Dec. 19, 2012
- Carla Mozee
U.S. Hot stocks to watch
7:28 a.m. July 18, 2012
- MarketWatch.com
U.S. may end patents on DNA: report
1:13 p.m. Oct. 30, 2010
- Christopher Hinton
Monday's biggest gaining and declining stocks
4:51 p.m. Oct. 5, 2009
- MarketWatch
3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus
1:25 p.m. Sept. 8, 2014
- benzinga.com
Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape
8:36 a.m. Sept. 3, 2014
- Zacks.com
InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical
10:13 a.m. Aug. 30, 2014
- Seeking Alpha
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
10:32 a.m. Aug. 27, 2014
- Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
9:49 a.m. Aug. 27, 2014
- Zacks.com
The Biotech Stock With The Best One-Week Performance
2:46 p.m. Aug. 25, 2014
- benzinga.com
Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog
4:55 p.m. Aug. 21, 2014
- Zacks.com
Perilous Reversal Stock: Amicus Therapeutics (FOLD)
9:45 a.m. Aug. 21, 2014
- TheStreet.com
Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape
9:39 a.m. Aug. 21, 2014
- Zacks.com
Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape
9:03 a.m. Aug. 21, 2014
- Zacks.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)
3:43 p.m. Aug. 20, 2014
- Seeking Alpha
Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today
10:29 a.m. Aug. 20, 2014
- TheStreet.com
Stocks Hitting 52-Week Highs
9:15 a.m. Aug. 20, 2014
- benzinga.com
Amicus Fabry disease drug candidate successful in Phase 3 trial
7:27 a.m. Aug. 20, 2014
- Seeking Alpha
Benzinga's Top #PreMarket Gainers
7:10 a.m. Aug. 20, 2014
- benzinga.com
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
6:01 a.m. Aug. 20, 2014
- TheStreet.com
Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript
9:37 p.m. Aug. 7, 2014
- Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC
5:07 p.m. Aug. 7, 2014
- Edgar Online - (EDG = 10Q, 10K)
Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape
8:44 a.m. Aug. 6, 2014
- Zacks.com
Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape
11:11 a.m. July 29, 2014
- Zacks.com
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics
8:40 a.m. Sept. 12, 2014
- PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo
8:40 a.m. Aug. 25, 2014
- PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
6:00 a.m. Aug. 20, 2014
- GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics
8:50 a.m. Aug. 13, 2014
- PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. Aug. 7, 2014
- GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
4:01 p.m. July 31, 2014
- GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis
8:50 a.m. July 30, 2014
- PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma
7:20 a.m. July 10, 2014
- PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc.
2:55 p.m. July 7, 2014
- PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array
6:30 a.m. July 3, 2014
- PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012
7:00 a.m. June 30, 2014
- GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum
8:20 a.m. June 4, 2014
- PR Newswire - PRF
Amicus Therapeutics to Present at UBS Global Healthcare Conference
4:10 p.m. May 14, 2014
- GlobeNewswire
Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. May 5, 2014
- GlobeNewswire
Dr. Farzad Mostashari to keynote SAS Health Analytics Executive
Conference
10:30 a.m. May 5, 2014
- BusinessWire - BZX
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus
8:00 a.m. May 2, 2014
- PR Newswire - PRF
Amicus Therapeutics to Announce First Quarter 2014
10:01 a.m. May 1, 2014
- GlobeNewswire
Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics
8:00 a.m. April 30, 2014
- PR Newswire - PRF
Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011
6:01 a.m. April 29, 2014
- GlobeNewswire
Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference
4:39 p.m. March 27, 2014
- GlobeNewswire
(0)
(0)Scroll down for more posts ▼